Yue Jiang Selected Research

Yue Jiang Research Topics

Disease

65	Neoplasms (Cancer) 07/2022 - 07/2010
19	Breast Neoplasms (Breast Cancer) 01/2022 - 06/2012
12	Carcinogenesis 11/2021 - 01/2011
11	Neoplasm Metastasis (Metastasis) 03/2022 - 04/2011
11	Infections 01/2022 - 12/2004
8	Inflammation (Inflammations) 07/2022 - 12/2004
8	Fibrosis (Cirrhosis) 01/2022 - 04/2013
7	Lung Neoplasms (Lung Cancer) 03/2022 - 01/2012
5	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2017
5	Hypoxia (Hypoxemia) 07/2021 - 01/2012
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 07/2012
4	Squamous Cell Carcinoma of Head and Neck 04/2022 - 12/2018
4	Ovarian Neoplasms (Ovarian Cancer) 10/2021 - 07/2010
4	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 10/2015
3	Hypertension (High Blood Pressure) 06/2022 - 08/2009
3	Liver Diseases (Liver Disease) 01/2022 - 01/2022
3	Carcinoma (Carcinomatosis) 01/2022 - 02/2010
3	Lung Injury 01/2022 - 05/2018
3	Hepatic Encephalopathy 01/2022 - 01/2020
3	Body Weight (Weight, Body) 12/2021 - 10/2016
3	Insulin Resistance 01/2020 - 08/2009
3	Adenomyosis 01/2019 - 01/2016
2	COVID-19 01/2022 - 01/2020
2	Asthma (Bronchial Asthma) 01/2022 - 01/2021
2	Hemorrhage 01/2022 - 09/2021
2	Colonic Neoplasms (Colon Cancer) 12/2021 - 01/2012
2	Chronic Renal Insufficiency 09/2021 - 04/2013
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 07/2021 - 10/2019
2	Wounds and Injuries (Trauma) 03/2021 - 11/2016
2	Anastomotic Leak 01/2021 - 01/2020
2	Genetic Risk Score 01/2021 - 01/2019
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020 - 10/2014
2	Adenocarcinoma of Lung 01/2020 - 01/2019
2	Adenocarcinoma 01/2020 - 01/2011
2	Ulcerative Colitis 01/2020 - 10/2019
2	Hypersensitivity (Allergy) 11/2019 - 08/2018
2	Radiation Pneumonitis 01/2019 - 05/2018
2	Mouth Neoplasms (Oral Cancer) 01/2019 - 01/2012
2	Ischemic Stroke 06/2017 - 03/2016
2	Genetic Predisposition to Disease (Genetic Predisposition) 11/2015 - 01/2014

Drug/Important Bio-Agent (IBA)

14	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2015
14	MicroRNAs (MicroRNA)IBA 01/2021 - 04/2011
12	Proteins (Proteins, Gene)FDA Link 03/2022 - 01/2012
9	Biological ProductsIBA 04/2022 - 02/2010
9	Messenger RNA (mRNA)IBA 11/2021 - 05/2011
9	Pharmaceutical PreparationsIBA 10/2021 - 10/2014
9	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 07/2010
8	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2017
6	Transcription Factors (Transcription Factor)IBA 03/2022 - 02/2014
6	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2021 - 04/2013
5	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2022 - 03/2017
5	Photosensitizing Agents (Photosensitizers)IBA 07/2021 - 03/2017
4	Therapeutic UsesIBA 04/2022 - 01/2020
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2015
4	InterleukinsIBA 07/2021 - 09/2016
4	Small Interfering RNA (siRNA)IBA 11/2019 - 02/2010
3	CollagenIBA 01/2022 - 04/2013
3	Glucose (Dextrose)FDA LinkGeneric 09/2021 - 08/2009
3	CytokinesIBA 07/2021 - 02/2014
3	LipidsIBA 01/2020 - 01/2014
3	Opioid Analgesics (Opioids)IBA 01/2020 - 01/2020
3	CarcinogensIBA 03/2014 - 01/2011
2	InterferonsIBA 01/2022 - 10/2021
2	Interleukin-17 (Interleukin 17)IBA 01/2022 - 05/2018
2	Nucleic AcidsIBA 01/2022 - 01/2020
2	AntigensIBA 01/2022 - 01/2021
2	Particulate MatterIBA 01/2022 - 01/2022
2	Epidermal Growth Factor (EGF)IBA 12/2021 - 02/2020
2	Antineoplastic Agents (Antineoplastics)IBA 12/2021 - 01/2019
2	AlbuminsIBA 12/2021 - 04/2013
2	EnzymesIBA 07/2021 - 01/2021
2	Antiviral Agents (Antivirals)IBA 01/2021 - 12/2004
2	Indicators and Reagents (Reagents)IBA 01/2021 - 10/2019
2	Heparin (Liquaemin)FDA LinkGeneric 02/2020 - 09/2014
2	Hormones (Hormone)IBA 01/2020 - 06/2012
2	BenzodiazepinesIBA 01/2020 - 11/2016
2	Matrix Metalloproteinases (MMPs)IBA 11/2019 - 05/2011
2	Retinaldehyde (Retinal)IBA 10/2019 - 03/2019
2	CholesterolIBA 09/2019 - 12/2004
2	Cell Adhesion MoleculesIBA 01/2019 - 05/2018
2	ProdrugsIBA 01/2019 - 12/2018
2	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2018 - 10/2014
2	Interleukin-10 (Interleukin 10)IBA 01/2018 - 05/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2017 - 02/2014
2	3' Untranslated Regions (3' UTR)IBA 08/2014 - 01/2012
2	ArsenicIBA 03/2014 - 01/2011
2	Advanced Glycation End ProductsIBA 04/2013 - 05/2011
2	Pyruvaldehyde (Methylglyoxal)IBA 04/2013 - 08/2009
2	SaltsIBA 04/2013 - 08/2009

Therapy/Procedure

18	Therapeutics 03/2022 - 10/2014
6	Immunotherapy 01/2022 - 11/2019
5	Photochemotherapy (Photodynamic Therapy) 01/2022 - 03/2017
4	Radiotherapy 01/2022 - 10/2014
4	Drug Therapy (Chemotherapy) 01/2020 - 01/2012
3	Liver Transplantation 01/2022 - 10/2015
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 11/2015
2	Phototherapy (Light Therapy) 12/2021 - 11/2019
2	Renal Dialysis (Hemodialysis) 09/2021 - 05/2008
2	Photothermal Therapy 01/2020 - 01/2019
2	Chemoradiotherapy 12/2018 - 05/2018